BioNexus Gene Lab Price to Book Ratio 2019-2025 | BGLC
Historical price to book ratio values for BioNexus Gene Lab (BGLC) over the last 10 years. The current price to book ratio for BioNexus Gene Lab as of July 30, 2025 is 1.66.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
BioNexus Gene Lab Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-07-30 | 7.18 | 16.60 | |
2025-03-31 | 2.36 | $0.43 | 5.46 |
2024-12-31 | 2.80 | $0.46 | 6.04 |
2024-09-30 | 4.45 | $5.23 | 0.85 |
2024-06-30 | 4.75 | $5.40 | 0.88 |
2024-03-31 | 7.06 | $5.29 | 1.33 |
2023-12-31 | 5.30 | $0.55 | 9.70 |
2023-09-30 | 8.70 | $5.44 | 1.60 |
2023-06-30 | 26.52 | $0.34 | 77.25 |
2023-03-31 | 64.80 | $4.53 | 14.30 |
2022-12-31 | 114.00 | $4.60 | 24.76 |
2022-09-30 | 127.20 | $4.44 | 28.65 |
2022-06-30 | 136.80 | $4.71 | 29.02 |
2022-03-31 | 205.20 | $5.00 | 41.06 |
2021-12-31 | 255.60 | $5.03 | 50.77 |
2021-09-30 | 141.60 | $4.94 | 28.64 |
2021-06-30 | 138.00 | $4.78 | 28.89 |
2021-03-31 | 252.00 | $4.76 | 52.91 |
2020-12-31 | 0.00 | $4.67 | 0.00 |
2020-09-30 | 0.00 | $1.09 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.013B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.067B | 27.09 |
CVS Health (CVS) | United States | $78.811B | 9.80 |
Elevance Health (ELV) | United States | $66.101B | 8.89 |
Cencora (COR) | United States | $56.558B | 19.68 |
DiDi Global (DIDIY) | China | $24.238B | 25.75 |
Labcorp Holdings (LH) | United States | $22.089B | 17.43 |
Natera (NTRA) | United States | $19.248B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $14.897B | 0.00 |
ICON (ICLR) | Ireland | $14.657B | 14.10 |
CochLear (CHEOY) | Australia | $13.278B | 0.00 |
Solventum (SOLV) | United States | $12.626B | 13.37 |
Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
Revvity (RVTY) | United States | $10.708B | 18.58 |
Viatris (VTRS) | United States | $10.563B | 3.63 |
Avantor (AVTR) | United States | $9.404B | 13.66 |
Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
HealthEquity (HQY) | United States | $8.544B | 37.42 |
Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
Sotera Health (SHC) | United States | $3.382B | 19.22 |
GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
Concentras Parent (CON) | United States | $2.615B | 15.11 |
Organon (OGN) | United States | $2.610B | 2.77 |
Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
Progyny (PGNY) | United States | $2.014B | 44.34 |
Premier (PINC) | United States | $1.772B | 13.45 |
GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
PACS (PACS) | United States | $1.710B | 0.00 |
Ardent Health (ARDT) | United States | $1.528B | 6.51 |
Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
Agilon Health (AGL) | United States | $0.791B | 0.00 |
CareDx (CDNA) | United States | $0.716B | 11.18 |
AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
Embecta (EMBC) | United States | $0.611B | 4.11 |
So-Young (SY) | China | $0.501B | 0.00 |
InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
Nutex Health (NUTX) | United States | $0.467B | 7.06 |
LifeMD (LFMD) | United States | $0.459B | 0.00 |
Omada Health (OMDA) | $0.455B | 0.00 | |
SBC Medicals (SBC) | United States | $0.455B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
Enhabit (EHAB) | United States | $0.338B | 27.83 |
Oncology Institute (TOI) | United States | $0.329B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
Beauty Health (SKIN) | United States | $0.202B | 0.00 |
DocGo (DCGO) | United States | $0.145B | 23.67 |
Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
KindlyMD (NAKA) | United States | $0.058B | 0.00 |
Biodesix (BDSX) | United States | $0.055B | 0.00 |
ModivCare (MODV) | United States | $0.044B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.001B | 0.00 |